# Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease

> **NCT02310269** · — · COMPLETED · sponsor: **RECORDATI GROUP** · enrollment: 152 (actual)

## Conditions studied

- Cushings Disease

## Interventions

- **DRUG:** Pasireotide

## Key facts

- **NCT ID:** NCT02310269
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-28
- **Primary completion:** 2023-07-10
- **Final completion:** 2023-07-10
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02310269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02310269, "Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02310269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*